Table 2. Incident cancer cases among U.S. Air Force fighter pilots and matched officers and rate ratio, diagnosis years 1995–2017a.
| Sex | Site | Fighter Pilots (n = 85) | Matched Officers (n = 932) |
Rate Ratiob (95% CI) |
|---|---|---|---|---|
| Male | All Malignant Cancers | 83 | 837 | 1.04 (0.83–1.31) |
| Oropharynx | 3 | 15 | 0.80 (0.22–2.86) | |
| Colon and Rectum | 9 | 49 | 0.94 (0.44–1.99) | |
| Bones and Joints | 3 | 2 | 1.42 (0.24–8.48) | |
| Soft Tissue including Heart | 1 | 1 | 1.26 (0.08–20.1) | |
| Melanoma of the Skin | 24 | 124 | 1.02 (0.64–1.62) | |
| Prostate | 2 | 34 | 1.29 (0.31–5.44) | |
| Testis | 19 | 81 | 0.92 (0.56–1.52) | |
| Kidney and Renal Pelvis | 1 | 4 | 1.45 (0.16–13.0) | |
| Brain and Other Nervous System | 4 | 21 | 0.97 (0.33–2.84) | |
| Thyroid | 2 | 16 | 1.31 (0.30–5.71) | |
| Urinary Bladder | 2 | 7 | 0.79 (0.16–3.89) | |
| Hodgkin Lymphoma | 2 | 12 | 0.59 (0.13–2.74) | |
| Non-Hodgkin Lymphoma | 5 | 37 | 1.15 (0.41–3.21) | |
| Leukemia | 3 | 10 | 0.84 (0.18–3.91) | |
| Miscellaneous Malignant Cancer | 1 | 4 | 0.99 (0.11–8.86) | |
| Female | All Malignant Cancers | 2 | 95 | 0.99 (0.25–4.04) |
| Melanoma of the Skin | 2 | 5 | 1.07 (0.20–5.71) |
aPersonnel entered the cohort between 1986 and 2006, and were followed for incident cancers from 1995 to 2017.
bRate ratio comparing fighter pilots to matched officers; each row of the data represents a unique matched group, requiring one cancer case per sex per age at cohort entry per age at cohort exit; consequently, the count of all malignant cancers (for males and females) will exceed the sum of the site-specific cancers.